CHATTEM SALES DECLINE 1.7% TO $20.8 MIL. IN FIRST QUARTER
This article was originally published in The Rose Sheet
Executive Summary
CHATTEM SALES DECLINE 1.7% TO $20.8 MIL. IN FIRST QUARTER (ended Feb. 28) due to the loss of Warner-Lambert as a major customer of its chemical division, Chattem said in a recent sales and earnings statement. Warner-Lambert terminated its arrangement with Chattem Chemicals when it reformulated Rolaids antacid in the middle of last year.